Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck

NCT01133678 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped Primary endpoint reached futility boundary

Conditions

Head and Neck Cancer

Interventions

DRUG: Everolimus
DRUG: Placebo

Sponsor

University of Chicago

Collaborators

[object Object]